GlassScriptPhysician profile
Hailey L Hall
NPI 1821293499
$3,207.27
in general payments reported to CMS, 2019-2025
14 companies · $113 in 2025
The $113 reported for 2025 was more than what a typical Maternal & Fetal Medicine provider received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $38.29 · 2021: $102 · 2022: $132 · 2023: $2,552 · 2024: $148 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,400 · Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,400.00 |
| Food and Beverage | $414.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $2,466.70 | 2023 | Myrisk |
| Abbvie INC. | $147.92 | 2019-2022 | |
| Exeltis, USA INC. | $109.84 | 2019-2024 | Slynd |
| Astellas Pharma US INC | $103.73 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $89.18 | 2024 | Myfembree |
| Hologic Sales and Service, LLC | $60.48 | 2022-2024 | Myosure Tissue Removal Device, Fluent Fluid Management System, Affirm Prone Biopsy System |
| Mayne Pharma Commercial LLC | $42.70 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.28 | 2019-2021 | |
| Coopersurgical, INC. | $38.44 | 2019-2021 | |
| Organon LLC | $27.38 | 2021-2023 | Nexplanon |
| Myovant Sciences INC. | $24.97 | 2022 | |
| Allergan, INC. | $23.90 | 2019-2020 | |
| Pfizer INC. | $17.59 | 2025 | |
| Daiichi Sankyo INC. | $13.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hailey Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.